ARVN Latest Headlines

Arvinas Holding Company (ARVN) Receives a Buy from Barclays

at www.tipranks.com (Wed, 17-Dec 4:17 AM)

ARV-806 Shows Best-in-Class Potential with 25-Fold Higher Potency in KRAS G12D-Mutated Cancer Models

Market Chameleon (Mon, 27-Oct 7:40 AM)

ARV-102 Demonstrates Robust Brain Penetration and Biomarker Reduction in Positive Phase 1 Trials: Implications for Parkinson’s and Beyond

Market Chameleon (Mon, 6-Oct 7:36 AM)